![]() CellFE CellFE is a company that develops a microfluidic device designed to deliver gene-editing molecules into the human cells. | ![]() Senti Biosciences Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies. | ![]() Avrobio Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease. | |||
Founding Date | Founding Date 2018 | Founding Date 2016 | Founding Date 2018 | Founding Date 2014 | Founding Date N/A |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Alameda, US HQ | Locations South San Francisco, US HQ | Locations The Woodlands, US HQ The Woodlands, US | Locations Hinxton, GB HQ | Locations Cambridge, US HQ |
Employees | Employees 287% decrease | Employees 916% decrease | Employees 8613% increase | Employees 468% decrease | Employees 8573% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.2 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 5.2 m |
Financial | |||||
Net income | Net income N/A | Net income ($61.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($74.2m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 4.8m (over 6 years ago) | Latest funding round N/A | Latest funding round $ 4m (over 7 years ago) | Latest funding round $ 50m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 4.8m | Total funding raised $ 53m | Total funding raised $ 4m | Total funding raised $ 82.2m | Total funding raised $ 85m |

Senti Biosciences (formerly known as Dynamics Special Purpose) leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.
View company
Othram is a company that provides forensic genealogy solutions.
View company
Congenica is a digital health company developing a genomic analytics platform.
View company
Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
View company